Fan Yan Xi - Net Worth and Insider Trading
Fan Yan Xi Net Worth
The estimated net worth of Fan Yan Xi is at least $5 Million dollars as of 2025-07-22. Fan Yan Xi is the senior management of China Resources Double-Crane Pharmaceutical Co Ltd and owns about 260,900 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) stock worth over $5 Million. Details can be seen in Fan Yan Xi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fan Yan Xi has not made any transactions after 2022-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Fan Yan Xi
Fan Yan Xi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fan Yan Xi owns 1 companies in total, including China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) .
Click here to see the complete history of Fan Yan Xi’s form 4 insider trades.
Insider Ownership Summary of Fan Yan Xi
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600062 | China Resources Double-Crane Pharmaceutical Co Ltd | 2022-12-15 | senior management |
Fan Yan Xi Latest Holdings Summary
Fan Yan Xi currently owns a total of 1 stock. Fan Yan Xi owns 260,900 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) as of December 15, 2022, with a value of $5 Million.
Latest Holdings of Fan Yan Xi
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600062 | China Resources Double-Crane Pharmaceutical Co Ltd | 2022-12-15 | 260,900 | 19.42 | 5,066,678 |
Holding Weightings of Fan Yan Xi
Fan Yan Xi Form 4 Trading Tracker
According to the SEC Form 4 filings, Fan Yan Xi has made a total of 2 transactions in China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in China Resources Double-Crane Pharmaceutical Co Ltd is the acquisition of 10,000 shares on December 15, 2022, which cost Fan Yan Xi around $227,500.
Insider Trading History of Fan Yan Xi
- 1
Fan Yan Xi Trading Performance
GuruFocus tracks the stock performance after each of Fan Yan Xi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fan Yan Xi is -22.37%. GuruFocus also compares Fan Yan Xi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fan Yan Xi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fan Yan Xi's insider trading performs compared to the benchmark.
Performance of Fan Yan Xi
Fan Yan Xi Ownership Network
Ownership Network List of Fan Yan Xi
Ownership Network Relation of Fan Yan Xi

Fan Yan Xi Owned Company Details
What does China Resources Double-Crane Pharmaceutical Co Ltd do?
Who are the key executives at China Resources Double-Crane Pharmaceutical Co Ltd?
Fan Yan Xi is the senior management of China Resources Double-Crane Pharmaceutical Co Ltd. Other key executives at China Resources Double-Crane Pharmaceutical Co Ltd include senior management han shuo , senior management Liu Zi Qin , and Directors & senior managers Lu Wen Chao .
China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062)'s detailed insider trading history can be found in Insider Trading Tracker table.
China Resources Double-Crane Pharmaceutical Co Ltd Insider Transactions
Fan Yan Xi Mailing Address
Above is the net worth, insider trading, and ownership report for Fan Yan Xi. Currently GuruFocus does not have mailing address information for Fan Yan Xi.